Vanta Bioscience P/B Ratio

Current P/B Ratio
0.66
Low Valuation
Low - Trading below book value, may indicate undervaluation

Vanta Bioscience (VANTABIO) P/B ratio is 0.66 (Low), book value per share ₹30.00 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see Vanta Bioscience stock price NSE.

Current Valuation Metrics

P/B Ratio 0.66
Current Price
Book Value/Share ₹30.00
Exchange None

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹21 Cr
Share Capital ₹7 Cr
Reserves & Surplus ₹14 Cr
Outstanding Shares 7,000,000
Book Value per Share ₹30.00

Valuation Signal

Signal Undervalued

Sector Context

Sector Average 0.0
Sector Median 0.61
Sector Rank #11 of 50
Sector Percentile 22.0%

VANTABIO P/B Ratio — Valuation Insights & Book Value Analysis

Vanta Bioscience price-to-book ratio interpretation, valuation status and historical context — current P/B 0.66 (Low). Also explore Vanta Bioscience share price performance to track price trends across different timeframes.

  • Stock appears undervalued with PB of 0.66, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at premium to sector average PB of 0.0

VANTABIO vs Healthcare Peers — P/B Ratio Comparison

Vanta Bioscience P/B 0.66 vs Healthcare average 0.0, median 0.61 — range -6.55–1.12.

Sector Average
0.0
Sector Median
0.61
Lowest P/B
-6.55
Highest P/B
1.12
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.12 ₹69 Low
Krebs Biochemicals & Ind… KREBSBIO -0.72 ₹116 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹54 Low
Triochem Products TRIPR 0.04 ₹0 Low